{
  "id": "cluster_0_doc1",
  "content": "Patient Fabrizio Wasicki presented with persistent neuropathy and rare antibody deficiency following an experimental gene therapy at Polk Health Network. Treatment included monthly immunoglobulin infusions and neuropathic pain management. Initial claims were denied due to experimental procedure coding, but later approved under policy exception #4419-7Q2. Last consultation on 11/15/2023 noted improvement in antibody levels.",
  "metadata": {
    "format": "medical_record"
  }
}